CSG’s Triple Threat: Short-Seller Attack, Shareholder Put, and EU Deadline Loom Over First Post-IPO Quarterly Report
14.05.2026 - 04:00:53 | boerse-global.de
The Czechoslovak Group enters a defining moment as three separate pressure points converge ahead of its inaugural quarterly earnings release since going public. A disputed put option worth €1.4 billion, allegations of inflated munitions capacity, and a fast-approaching deadline to secure cheap EU financing for a €58 billion framework agreement are all vying for investor attention – and none are likely to be resolved by the numbers alone.
Trading around €16.00 on Wednesday, the stock sits just above its 52-week low of €15.73. The sell-off has been brutal: a 26.5% drop over the past 30 days has erased more than half the value from January’s peak of €33.81. Even a 71.7% revenue surge to €6.7 billion last year and a net profit of €872 million have done little to stem the tide of skepticism.
At the heart of the doubt is a high-profile attack by Hunterbrook Media, whose linked hedge fund holds a disclosed short position. The short-seller claims CSG’s stated annual production capacity of around 630,000 rounds of large-calibre ammunition – 80% of which is 155mm artillery shells – is not visible at the Dubnica assembly plant. Hunterbrook estimates output was between 100,000 and 280,000 rounds last year. CSG rejects the assertion, maintains its 2025 capacity figure, and says it is considering legal action. Management has guided for roughly 20% capacity growth this year, with an additional 70,000 rounds to come from a new Slovak line. The medium-term target stands at 1.1 million rounds.
A separate governance storm adds to the friction. Czech media report that minority shareholder Petr KratochvĂl, who holds a 10% stake in CSG Land Systems and retains veto rights over key decisions, attempted to exercise a put option shortly before the IPO, demanding roughly €1.4 billion. CSG says it has external legal advice that the option was not effectively exercised before listing, and therefore records no balance-sheet liability or contingent obligation. The company has also confirmed that a €275 million receivable from the pre-IPO sale of its non-core Mobility, Perazzi and Healthcare divisions was fully settled in the first quarter.
Should investors sell immediately? Or is it worth buying CSG?
Meanwhile, a €58 billion Slovak munitions framework agreement – the sort of contract that could supercharge order intake – depends on securing a second EU member state to co-finance it through the bloc’s SAFE programme. The interest rate would be just 1% if at least two countries participate, but the preferential window closes at the end of May. So far, Romania has denied ministerial-level talks and Croatia is still weighing its options. CSG stresses that the framework is a maximum potential value, not a guaranteed order, and that its business does not hinge on a single EU funding channel.
A secondary catalyst lies in Austria. CSG has agreed to acquire 49% of Hirtenberger Defence Systems, a specialist in mortar munitions and systems, from Hungary’s 4iG Group. The deal would broaden the product portfolio and mark the group’s first Austrian acquisition. It also includes exploring a possible joint venture in Slovakia for selected assembly. Regulatory approval is still pending, and analysts see a green light as a potential near-term share price trigger for a stock that currently has little buffer.
On the sell side, sentiment remains unusually upbeat. Nine analysts rate the stock a Buy, with an average price target of €35.40 – more than double the current level. For the 2026 financial year, CSG expects revenue of €7.4–€7.6 billion and an adjusted EBIT margin of 24% to 25%. Its order backlog stood at €15 billion going into the year, with a project pipeline of €27 billion.
CSG at a turning point? This analysis reveals what investors need to know now.
The first-quarter report due May 20 will bundle IPO-related costs, margin quality, and the company’s ability to make operational strength and capacity claims more tangible. If CSG can convince the market that its production figures are solid and that the governance issues are contained, the risk premium may start to unwind. If not, the stock’s slide may have further to run before any of those looming deadlines provide relief.
Ad
CSG Stock: New Analysis - 14 May
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis CSG’s Aktien ein!
FĂĽr. Immer. Kostenlos.
